Media & Entertainment » Movie, TV & Radio | American Cryostem Corp.

American Cryostem Corp. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11.50
121.00
299.00
593.90
1,865.40
1,103.40
Cost of Goods Sold (COGS) incl. D&A
47.70
-
137.80
333.40
592.00
324
Gross Income
36.10
-
161.20
260.50
1,273.40
779.40
SG&A Expense
2,085.40
1,970.20
1,355.80
1,554.90
2,169.40
2,019.70
EBIT
2,121.50
1,890.00
-
1,294.30
896.10
1,240.20
Unusual Expense
-
-
-
-
236.60
96.40
Non Operating Income/Expense
-
-
39.90
17.20
2.00
53.90
Interest Expense
278.20
198.10
224.80
604.00
91.30
99.90
Pretax Income
2,399.70
2,088.10
1,379.50
1,881.10
1,222.00
1,490.50
Consolidated Net Income
2,399.70
2,088.10
1,379.50
1,881.10
1,222.00
1,490.50
Net Income
2,399.70
2,088.10
1,379.50
1,881.10
1,222.00
1,490.50
Net Income After Extraordinaries
2,399.70
2,088.10
1,379.50
1,881.10
1,222.00
1,490.50
Net Income Available to Common
2,399.70
2,088.10
1,379.50
1,881.10
1,222.00
1,490.50
EPS (Basic)
0.08
0.06
0.04
0.05
0.03
0.03
Basic Shares Outstanding
29,472.80
32,607.10
33,044.30
35,879.10
37,973.80
46,216.40
EPS (Diluted)
0.08
0.06
0.04
0.05
0.03
0.03
Diluted Shares Outstanding
29,472.80
32,607.10
33,044.30
35,879.10
37,973.80
46,216.40
EBITDA
2,079.00
1,849.20
1,153.70
1,254.90
858.60
1,213.20

About American Cryostem

View Profile
Address
1 Meridian Road
Eatontown New Jersey 07724
United States
Employees -
Website http://www.americancryostem.com
Updated 07/08/2019
American CryoStem Corp. engages in the development, market, and licenses patented adipose tissue-based cellular technologies, bio-materials, and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and adipose-derived stem cells; and also provides contract manufacturing services to physicians and other medical professionals that perform tissue transfer and other cellular therapy services, as well as offers professional services, including sterility, viability, cellular density, and growth assay analysis. The company was founded by Anthony Francis Dudzinski on November 18, 2008 and is headquartered in Eatontown, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.